Afterpay Touch Group (ASX:APT) shares rise on final audit for AUSTRAC: ASX tracking 0.6% higher at noon

  • Home
  • Latest Market News
  • Afterpay Touch Group (ASX:APT) shares rise on final audit for AUSTRAC: ASX tracking 0.6% higher at noon
25Nov

Afterpay Touch Group (ASX:APT) shares rise on final audit for AUSTRAC: ASX tracking 0.6% higher at noon

 

The Australian share market rose at the open and is now tracking 0.6 per cent higher at noon. The Afterpay Touch Group (ASX:APT) shares shot up on the back of its final audit provided to AUSTRAC. Caltex Australia (ASX:CTX) shares are also on the rise today after they reported they intend to float stake in 250 retail sites. Nufarm (ASX:NUF) shares are down after it flagged a weak first quarter and looks likely their earnings will take a hit.

The S&P/ASX 200 index is 39 points up at 6,748. On the futures market the SPI is 32 points higher.

Broker moves

Citi has upgraded Grocery distributor Metcash (ASX:MTS) to a Neutral from a Sell, with a 12-month price target of $2.80. Last week Metcash confirmed the loss of one of its largest customers, 7-Eleven. The broker expects Metcash will retain around 10 per cent of the contract in Western Australia and selected categories. Shares in Metcash (ASX:MTS) are currently flat at $2.83.

Company news

As part of its Annual General Meeting today, Healius (ASX:HLS) announced that underlying NPAT for FY 2020 is expected to be between $94 million and $102 million. At the top end of the range, this equates to a 9.4 per cent increase, in line with the seasonally-adjusted run-rate from the second half of 2019. This updates the guidance announced on 16 August 2019, for underlying NPAT to be higher than FY 2019. Additionally, Healius today announced further changes to its management team. Shares in Healius (ASX:HLS) are currently 3.2 per cent lower at $3.02.

Australian stem cell and regenerative medicine company, Cynata Therapeutics (ASX:CYP) has filed a Clinical Trial Authorisation application with the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the proposed Phase 2 clinical trial of Cynata’s Cymerus™ stem cell (MSC) product CYP-002 in patients with critical limb ischaemia ish·skee·mee·uh (CLI). CLI is an advanced stage of peripheral artery disease (PAD), which is a narrowing of arteries in the limbs, particularly the legs. Shares in Cynata Therapeutics (ASX:CYP) are 1.7 per cent higher at $1.21.

Best and worst performers

The best-performing sector is Energy, adding 1.4 per cent, while the worst performing sector is Consumer Discretionary, gaining the least at 0.1 per cent.

The best performing stock in the S&P/ASX 200 is AfterPay Touch Group (ASX:APT) rising 10.1 per cent to $33.56, followed by shares in Caltex (ASX:CTX) and Pilbara Minerals (ASX:PLS)

The worst performing stock in the S&P/ASX 200 is Nufarm (ASX:NUF), dropping 18 per cent to $5.05, followed by shares in Polynovo (ASX:PNV) and Pro Medicus (ASX:PME).

Commodities and the dollar

Gold is trading at US$1,460 an ounce.
Iron ore price rose 1.6 per cent to US$88.08.
Iron ore futures are pointing to a rise of 1.7 per cent.
One Australian dollar is buying 67.94 US cents.
 
Copyright 2019 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

18Nov

Prospa Group sinks on profit downgrade: Aus shares close 0.4% lower

18 Nov 2019 - Its been a softer start to the week for the Australian sharemarket despite a strong lead in from Wall Street. There were losses across the board with 8 out of 10 sectors in the red led by utilities which was down over 1 per cent. Financials was another of the main weights with the big 4 all lower and and health stocks such as CSL were also lower.

Read More
27Sep

Wall St mixed, China bans crypto: Premier is an outperform: ASX to open flat

27 Sep 2021 - Mixed market across the globe as major indexes attempted to stride back to record highs. Evergrande woes have faded for now, investors are looking closely on Beijing's next moves after banning all cryptocurrency transactions. Overview of last week's M&A's on the local bourse. Why Macquarie rated Premier Investments (ASX:PMV) as an outperform.

Read More
01Dec

Stocks fly as Fed Reserve suggests rate hikes to slow

01 Dec 2022 - Stocks climbed Wednesday as Federal Reserve Chair Jerome Powell confirmed that the central bank will slow the pace of its aggressive rate-hiking campaign that has weighed on markets. Commodities prices, factory gate prices, energy prices and inflation expectations have all begun to slide from their record levels, suggesting to some that the pace of headline price growth is set to slow in 2023.

Read More
31Mar

Oil crashes to an 18-year low: ASX poised to open higher

31 Mar 2020 - We saw a surge on the markets yesterday closing 7% higher – this movement is expected to continue with the ASX expected to open higher this morning. European governments moved to tighten restrictions to contain the coronavirus outbreak with an unrelenting rise in infections and deaths. Air New Zealand (ASX:AIZ) will begin reducing its workforce from this week as the severe economic impact of COVID-19 hits the airline.

Read More
21Dec

Markets flat but trillion dollar losses for 5 tech stocks this year

21 Dec 2022 - Stocks rose Tuesday as Wall Street shook off a surprise move from the Bank of Japan that sent global bond yields up. It’s been a rough year for stocks, from the market’s yearly high on January 3 to this morning, US stocks have shed $11.7 trillion in market cap and of the $11.7 trillion, more than $5 trillion in losses come from just five companies - Apple, Microsoft, Amazon, Alphabet, Meta and Tesla.

Read More
26May

Wall St loses momentum, gold climbs near 4-month high: ASX to fall

26 May 2021 - The ASX is set to fall following Wall St closing in the red as all three indexes reversed their gains. Morgan Stanley rates Synlait Milk (ASX:SM1) as a hold with a price target of $2.55. Profit results from ALS (ASX:ALQ) and Mesoblast (ASX:MSB) are due today.

Read More
19Mar

Pilbara Minerals (ASX:PLS) launches digital trading platform: ASX closed 0.7% lower

18 Mar 2021 - It's been a negative day of trade for the local market. After opening almost flat, the market continued to slide, extending yesterday's drop to close 49 points down. After data was released showing a better than expected improvement in the unemployment rate, the index lifted by 0.4 per cent. However, it failed to hang onto these gains. The S&P 500 and Dow Jones Industrial Average closed at record highs overnight after the US Federal Reserve...

Read More
15Dec

Markets slid as Rio Tinto targets lithium

15 Dec 2022 - Stocks slid Wednesday as the Fed delivered a widely-anticipated 50 basis point rate hike at the conclusion of its December policy meeting. And Tesla shareholders are becoming increasingly worried that Musk is too distracted by his work at Twitter. The electric carmaker’s stock is down 52 percent this year.

Read More
30Dec

Wall St mixed on S&P 500 70th record close, M&As in lithium sector to gear up: ASX poised to rise

30 Dec 2021 - Mixed closed around the major indexes around the globe on thin volume. M&As in lithium sector to gear up with 48 companies set to trade ex-div on ASX today.

Read More
09Jul

The price of iron ore hits a 2020 high: ASX set to open higher

09 Jul 2020 - Following small gains from US markets overnight, the ASX looks set to open higher this morning. The US is seeing some fluctuation in the markets as investors weigh up the economic recovery from the pandemic. Back home Victorian farmers are struggling to place their products as many Melbourne restaurants return to lockdown. Iron ore saw a sharp rise in price. Rio Tinto gives contract termination notice to Meridian (ASX:MEZ).

Read More